These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
172 related items for PubMed ID: 7532743
1. Charge selectivity and urine amylase isoenzymes. Recio F, Villamil F. Kidney Int Suppl; 1994 Nov; 47():S89-92. PubMed ID: 7532743 [Abstract] [Full Text] [Related]
5. Urinary excretion of beta-thromboglobulin and N-acetyl-beta-D-glucosaminidase in type 1 diabetes: potential indicators of early nephropathy? Patrick AW, Oliver MD, Howie AF, Dawes J, Macintyre CC, Frier BM. Diabete Metab; 1990 Nov; 16(5):441-7. PubMed ID: 2150050 [Abstract] [Full Text] [Related]
6. Measurement of glomerular charge selectivity in non-diabetic renal disease. Hemmelder MH, de Zeeuw D, de Jong PE. Nephrol Dial Transplant; 1997 Nov; 12 Suppl 2():57-62. PubMed ID: 9269702 [Abstract] [Full Text] [Related]
7. Effects of aerobic exercise on microalbuminuria and enzymuria in type 2 diabetic patients. Lazarevic G, Antic S, Vlahovic P, Djordjevic V, Zvezdanovic L, Stefanovic V. Ren Fail; 2007 Nov; 29(2):199-205. PubMed ID: 17365936 [Abstract] [Full Text] [Related]
8. Urinary activities of cathepsin B, N-acetyl-beta-D-glucosaminidase, and albuminuria in patients with type 2 diabetes mellitus. Piwowar A, Knapik-Kordecka M, Fus I, Warwas M. Med Sci Monit; 2006 May; 12(5):CR210-4. PubMed ID: 16641878 [Abstract] [Full Text] [Related]
9. Comparison of urinary excretion of albumin, alpha 1-microglobulin and retinol-binding protein in diabetic patients. Galanti LM, Jamart J, Dell'omo J, Donckier J. Diabetes Metab; 1996 Oct; 22(5):324-30. PubMed ID: 8896994 [Abstract] [Full Text] [Related]
10. Urinary glycosaminoglycan and proteoglycan excretion in normoalbuminuric patients with type 1 diabetes mellitus. De Muro P, Fresu P, Formato M, Tonolo G, Mameli M, Maioli M, Sanna GM, Cherchi GM. J Nephrol; 2002 Oct; 15(3):290-6. PubMed ID: 12113601 [Abstract] [Full Text] [Related]
11. Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus. Awadallah SM, Saleh SA, Abu Shaqra QM, Hilow H. J Diabetes Complications; 2008 Oct; 22(6):384-8. PubMed ID: 18413152 [Abstract] [Full Text] [Related]
12. Prevalence of microalbuminuria in diabetic subjects. Sheth J, Trivedi B, Shah L, Sheth VS. J Assoc Physicians India; 1993 Sep; 41(9):562-4. PubMed ID: 8307909 [Abstract] [Full Text] [Related]
13. Renal clearance of pancreatic and salivary amylase relative to creatinine clearance in patients with renal disease and proteinuria. Wetzels JF, Hafkenscheid JC, Hessels M, Hoitsma AJ, Koene RA. Clin Chem; 1988 Mar; 34(3):589-91. PubMed ID: 2450698 [Abstract] [Full Text] [Related]
14. [Cytokines in noninvasive diagnostics of diabetic nephropathy progression]. Senatorski G, Paczek L, Kropiewnicka E, Bartłomiejczyk I. Pol Merkur Lekarski; 2002 Nov; 13 Suppl 1():28-32. PubMed ID: 12621778 [Abstract] [Full Text] [Related]
15. Proteinuria in children with sickle cell disease. Marsenic O, Couloures KG, Wiley JM. Nephrol Dial Transplant; 2008 Feb; 23(2):715-20. PubMed ID: 18065783 [Abstract] [Full Text] [Related]
16. Diabetic nephropathy in children with type 1 diabetes mellitus in Bahrain. Al-Hermi BE, Al-Abbasi AM, Rajab MH, Al-Jenaidi FA, Al-Ekri ZE. Saudi Med J; 2005 Feb; 26(2):294-7. PubMed ID: 15770309 [Abstract] [Full Text] [Related]
17. [Excretion of beta-N-acetylglucosaminidase in urine in type I and type II diabetic patients with and without nephropathy]. Werle E, Bostedt A, Fiehn W, Hasslacher C. Wien Klin Wochenschr Suppl; 1991 Feb; 189():59-62. PubMed ID: 1962487 [Abstract] [Full Text] [Related]
18. Biochemical analysis of serum pancreatic amylase and lipase enzymes in patients with type 1 and type 2 diabetes mellitus. Aughsteen AA, Abu-Umair MS, Mahmoud SA. Saudi Med J; 2005 Jan; 26(1):73-7. PubMed ID: 15756357 [Abstract] [Full Text] [Related]
19. Urinary tumour necrosis factor-alpha excretion independently correlates with clinical markers of glomerular and tubulointerstitial injury in type 2 diabetic patients. Navarro JF, Mora C, Muros M, García J. Nephrol Dial Transplant; 2006 Dec; 21(12):3428-34. PubMed ID: 16935891 [Abstract] [Full Text] [Related]
20. Melatonin reduces urinary excretion of N-acetyl-beta-D-glucosaminidase, albumin and renal oxidative markers in diabetic rats. Oktem F, Ozguner F, Yilmaz HR, Uz E, Dündar B. Clin Exp Pharmacol Physiol; 2006 Dec; 33(1-2):95-101. PubMed ID: 16445706 [Abstract] [Full Text] [Related] Page: [Next] [New Search]